Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2011
11/24/2011WO2011091360A3 Optical time reversal by ultrasonic encoding in biological tissue
11/24/2011WO2011091106A3 Compositions and methods for gene signature - based chemical screening
11/24/2011WO2011088927A3 Coplanar waveguide mounted on an ltcc (low-temperature co-fired ceramic) substrate for measuring dielectric properties of liquid media, in particular for determining the alcohol content of fuel mixtures
11/24/2011WO2011088385A3 Compositions and methods for detecting cancer
11/24/2011WO2011085258A3 Fluidics interface system
11/24/2011WO2011085165A3 Ca-125 immune complexes as biomarkers of ovarian cancer
11/24/2011WO2011084791A3 Early marker of proteinuria in patients treated with an anti-vegf treatment
11/24/2011WO2011082416A3 Peripherin-specific autoantibodies as a marker for neurological and endocrinological disease
11/24/2011WO2011078880A3 Solution analysis using atmospheric pressure ionization techniques
11/24/2011WO2011075715A3 Histology slide and paraffin block protector and transport sleeve
11/24/2011WO2011073137A3 Compounds for imaging apoptotic cell death
11/24/2011WO2011072065A3 Microbially-based sensors for environmental monitoring
11/24/2011WO2011071359A3 Covalent modification of proteins for the instantaneous visualisation thereof and subsequent characterisation through mass spectrometry
11/24/2011WO2011063283A3 Methods for detecting a mycobacterium tuberculosis infection
11/24/2011WO2011063198A3 Methods and compositions for modulating the activity of the interleukin-35 receptor complex
11/24/2011WO2011062469A3 Diagnostic method for detecting acute kidney injury using heat shock protein 72 as a sensitive biomarker
11/24/2011WO2011060101A3 Turbidity suppression by optical phase conjugation using a spatial light modulator
11/24/2011WO2011033302A3 Insecticide derived from campylobacter bacteria
11/24/2011WO2008153685A9 Progenitor cells from urine and methods for using the same
11/24/2011US20110289605 Animal Model for Osteoarthritis and Intervertebral Disc Disease
11/24/2011US20110289604 Methods for Identifying Modulating Compounds of Lymphangiogenesis, Means Therefore, Compounds and Uses Thereof
11/24/2011US20110289022 Methods for Plant Fiber Characterization and Identification
11/24/2011US20110288788 Prediction of wax appearance temperature and solid wax amount by reduced spectral analysis using ftir spectroscopy
11/24/2011US20110288781 Systems and methods for characterizing a biological condition or agent using selected gene expression profiles
11/24/2011US20110288430 Gas Sensor
11/24/2011US20110288275 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/24/2011US20110288153 Translation factors as anti-aging drug targets
11/24/2011US20110288151 Methods of characterizing breast cancer and identifying treatments for same
11/24/2011US20110288102 Il-8 biomarker for monitoring cancer treatment
11/24/2011US20110288046 Analysis of sulfated polysacchrides
11/24/2011US20110288034 Methods of identifying adipocyte specific genes, the genes identified, and their uses
11/24/2011US20110288031 Identification of a novel bhd gene
11/24/2011US20110288013 Glycemic control for reduction of cardiovascular disease risk in diabetic patients expressing haptoglobin 2-2
11/24/2011US20110287979 Methods for Identifying and Isolating Cells Expressing a Polypeptide
11/24/2011US20110287969 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
11/24/2011US20110287964 Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans
11/24/2011US20110287958 Method for Using Gene Expression to Determine Colorectal Tumor Stage
11/24/2011US20110287955 Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis
11/24/2011US20110287950 Protein fragment complementation assays for the detection of biological or drug interactions
11/24/2011US20110287949 Methods for detecting and treating cancer
11/24/2011US20110287948 Measurement of material properties and related methods and compositions based on cytoadherence
11/24/2011US20110287559 Method of characterizing glycans attached to glycoproteins
11/24/2011US20110287556 Blood group antigens of different types for diagnostic and therapeutic applications
11/24/2011US20110287550 Method for continuously monitoring solution-phase synthesis of oligonucleotide
11/24/2011US20110287491 Complexity Management of Genomic DNA
11/24/2011US20110287480 Neurogenin
11/24/2011US20110287465 Characterization of o-linked glycans
11/24/2011US20110287460 Method of lipid assay and reagent for use therein
11/24/2011US20110287458 Method and composition for the diagnosis and monitoring of inflammatory diseases
11/24/2011US20110287457 Compositions and methods for diagnosing and treating an inflammation
11/24/2011US20110287456 Synthetic peptides, methods and kits for diagnosing autoimmune diseases
11/24/2011US20110287455 Methods, Devices and Kits for Detecting or Monitoring Acute Kidney Injury
11/24/2011US20110287454 Methods for monoclonal antibody production
11/24/2011US20110287453 Antibody binding specifically to tdp-43 aggregate
11/24/2011US20110287452 Test Kit for Detecting Klebsiella Pneumoniae Serotype K1 and Method Using Same
11/24/2011US20110287451 Novel anti cxcr4 antibodies and their use for the treatment of cancer
11/24/2011US20110287450 Methods For Diagnosing And Monitoring The Progression Of Cancer
11/24/2011US20110287449 Myeloperoxidase, a risk indicator for cardiovascular disease
11/24/2011US20110287448 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
11/24/2011US20110287447 Apparatus for and method of automated processing of biological samples
11/24/2011US20110287446 Immunoanalytical method and system using mass spectrometry technology
11/24/2011US20110287445 Mutant ROS Expression In Human Cancer
11/24/2011US20110287444 Immunoassay method for human cxcl1 protein
11/24/2011US20110287443 High level expression of recombinant toxin proteins
11/24/2011US20110287442 Tumor Antigen Protein, Gene, or Peptides from Topoisimerase 2 Alpha
11/24/2011US20110287440 Composition and method for reconstituting IkB kinase in yeast and method of using same
11/24/2011US20110287438 Sensor chip for screening topoisomerase inhibitor and screening method thereof
11/24/2011US20110287434 Pregnancy testing
11/24/2011US20110287433 Methods and Kits for the Rapid Determination of Patients at High Risk of Death During Severe Sepsis and Septic Shock
11/24/2011US20110287431 Modified oligonucleotides and applications thereof
11/24/2011US20110287429 Use of haploid genomes for genetic diagnosis, modification and multiplication
11/24/2011US20110287423 Diagnosis of viral infections by detection of genomic and infectious viral dna by molecular combing
11/24/2011US20110287420 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or WNT
11/24/2011US20110287414 Systems and methods for identifying a portion of a molecule
11/24/2011US20110287413 Microfluidic system
11/24/2011US20110287410 Hepatitis-c virus testing
11/24/2011US20110287409 Diagnostic device and method
11/24/2011US20110287406 Novel HCV core+1 protein, methods for diagnosis of HCV infections, prophylaxis, and for screening of anti-HCV agents
11/24/2011US20110287146 Packaging assembly
11/24/2011US20110287059 Honey analysis
11/24/2011US20110287056 Agents and methods to elicit anti-tumor immune response
11/24/2011US20110287049 Prevention and treatment of amyloidogenic diseases
11/24/2011US20110287043 Melanoma antigens and their use in diagnostic and therapeutic methods
11/24/2011US20110287029 Inhibition of the beta3 subunit of l-type ca2+ channels
11/24/2011US20110287025 Combination therapy and method for assessing resistance to treatment
11/24/2011US20110287022 Interferon alpha-induced pharmacodynamic markers
11/24/2011US20110287015 Mg53 compositions and methods of use
11/24/2011US20110287011 DDR1-Binding Agents and Methods of Use Thereof
11/24/2011US20110287010 Diagnostic methods and markers
11/24/2011US20110287005 Monoclonal antibodies against amyloid beta protein and uses thereof
11/24/2011US20110286997 Genetic Alterations on Chromosome 16 and Methods of Use Thereof for the Diagnosis and Treatment of Type 1 Diabetes
11/24/2011US20110286990 Methods of diagnosing and treating fibrosis
11/24/2011US20110286977 G6PC2-Encoded Beta Cell Surface Tags
11/24/2011US20110286973 Methods for introducing heterologous cells into fish
11/24/2011US20110286928 Methods and compositions for inhibition of BCL6 repression
11/24/2011US20110286921 18f-labelled folates as pet radiotracers
11/24/2011US20110286917 Novel, Prostate-Specific Gene for Diagnosis, Prognosis and Management of Prostate Cancer
11/24/2011US20110286916 Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use
11/24/2011US20110286887 Open type groove channel chip
11/24/2011US20110286885 Microfluidic device having normally open type microvalve and method of manufacturing the microfluidic device